{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:59:15Z","timestamp":1768280355548,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejmech.2023.115445","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T20:52:20Z","timestamp":1683060740000},"page":"115445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Hit-to-lead optimization of a pyrazinylpiperazine series against Leishmania infantum and Leishmania braziliensis"],"prefix":"10.1016","volume":"256","author":[{"given":"Thibault Joseph William","family":"Jacques Dit Lapierre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariza Gabriela Faleiro de Moura Lodi","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00edcolas Peterson Ferreira","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela de Melo","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe de Oliveira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Jorge","family":"Pilau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryck Felipe Brito","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Junior","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvane Maria Fonseca","family":"Murta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-2035","authenticated-orcid":false,"given":"Celso de Oliveira","family":"Rezende J\u00fanior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115445_bib2","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/cr500365f","article-title":"Recent developments in drug discovery for leishmaniasis and human african trypanosomiasis","volume":"114","author":"Nagle","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115445_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115445_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03240-z","article-title":"Sand flies: basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites","volume":"5","author":"Cec\u00edlio","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2023.115445_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115445_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115445_bib8","doi-asserted-by":"crossref","DOI":"10.5812\/pedinfect.31612","article-title":"Visceral leishmaniasis: an update and literature review","volume":"4","author":"Karimi","year":"2016","journal-title":"Arch. Pediatr. Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115445_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0009181","article-title":"The global procurement landscape of leishmaniasis medicines","volume":"15","author":"Choi","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115445_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14787210.2019.1555471","article-title":"Understanding the economic impact of leishmaniasis on households in endemic countries: a systematic review","volume":"17","author":"Sunyoto","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2023.115445_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00048-18","article-title":"Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2023.115445_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"Freitas-Junior","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115445_bib13","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"A review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115445_bib15","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1021\/acs.jmedchem.7b01581","article-title":"Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H -imidazo[2,1- b] [1,3]oxazine (DNDI-8219): a new lead for visceral leishmaniasis","volume":"61","author":"Thompson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1039\/D0MD00165A","article-title":"Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents","volume":"11","author":"Koovits","year":"2020","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114577","article-title":"Hit-to-lead optimization of novel phenyl imidazole carboxamides that are active against Leishmania donovani","volume":"240","author":"McNamara","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib18","doi-asserted-by":"crossref","first-page":"9615","DOI":"10.1021\/acs.jmedchem.5b01456","article-title":"Novel amino-pyrazole ureas with potent in vitro and in vivo antileishmanial activity","volume":"58","author":"Mowbray","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib19","doi-asserted-by":"crossref","first-page":"16159","DOI":"10.1021\/acs.jmedchem.1c01437","article-title":"DNDI-6148: a novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis","volume":"64","author":"Mowbray","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114996","article-title":"Design and synthesis of novel halogen rich salicylanilides as potential antileishmanial agents","volume":"246","author":"Lal","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009196","article-title":"2-aminobenzimidazoles for leishmaniasis: from initial hit discovery to in vivo profiling","volume":"15","author":"Ferreira","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2023.115445_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep08771","article-title":"New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource","volume":"5","author":"Pe\u00f1a","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115445_bib23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115445_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756366.2019.1693704","article-title":"Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3","volume":"35","author":"Mart\u00ednez de Iturrate","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.7439\/ijasr.v1i1.1766","article-title":"Piperazine and Pyrazine containing molecules and their diverse pharmacological activities","volume":"1","author":"Asif","year":"2015","journal-title":"Int. J. Adv. Sci. Res."},{"key":"10.1016\/j.ejmech.2023.115445_bib26","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/jcp.24023","article-title":"Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes","volume":"227","author":"Oberweis","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2023.115445_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2019.127040","article-title":"Synthesis, characterisation, crystal structures, anticoagulant and antiplatelet activity studies of new 2,6-dipyrazinylpyridines with pendant trimethoxyphenyl","volume":"1200","author":"Ramesh","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2023.115445_bib28","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S1359-6446(04)03280-5","article-title":"Improving the decision-making process in structural modification of drug candidates: enhancing metabolic stability","volume":"9","author":"Nassar","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115445_bib29","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1021\/acs.jmedchem.9b01813","article-title":"Integrating the impact of lipophilicity on potency and pharmacokinetic parameters enables the use of diverse chemical space during small molecule drug optimization","volume":"63","author":"Miller","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib30","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115445_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","article-title":"Lessons learnt from assembling screening libraries for drug discovery for neglected diseases","volume":"3","author":"Brenk","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115445_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ng2053","article-title":"Comparative genomic analysis of three Leishmania species that cause diverse human disease","volume":"39","author":"Peacock","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2023.115445_bib33","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.122945.111","article-title":"Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania","volume":"21","author":"Rogers","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.ejmech.2023.115445_bib34","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib35","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.jmedchem.8b01218","article-title":"Identification of GSK3186899\/DDD853651 as a preclinical development candidate for the treatment of visceral leishmaniasis","volume":"62","author":"Thomas","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib36","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115445_bib37","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17460441.2017.1344210","article-title":"Lipophilicity and biomimetic properties to support drug discovery","volume":"12","author":"Tsopelas","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115445_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2016.01.018","article-title":"Molecular inflation, attrition and the rule of five","volume":"101","author":"Leeson","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2023.115445_bib39","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/jm201388p","article-title":"Impact of lipophilic efficiency on compound quality","volume":"55","author":"Tarcsay","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115445_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114421","article-title":"Identification and development of a series of disubstituted piperazines for the treatment of Chagas disease","volume":"238","author":"McGonagle","year":"2022","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423004117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:52:26Z","timestamp":1759330346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423004117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S0223523423004117"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115445","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hit-to-lead optimization of a pyrazinylpiperazine series against Leishmania infantum and Leishmania braziliensis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115445"}}